INTRAVENOUS THROMBOLYSIS AND CLOT RETRIEVAL FOLLOWING REVERSAL OF DABIGATRAN WITH IDARUCIZUMAB

被引：1
|
作者：
Tse, Dominic M. Y. [1 ]
Young, Laura [2 ]
Ranta, Anna M. [3 ]
Barber, P. A. [1 ]
机构：
[1] Auckland Dist Hlth Board, Dept Neurol, Auckland, New Zealand
[2] Auckland Dist Hlth Board, Dept Haematol, Auckland, New Zealand
[3] Univ Otago, Auckland, New Zealand
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2017年 / 88卷 / 05期
关键词：
D O I：
10.1136/jnnp-2017-316074.7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
7
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Idarucizumab: A Review as a Reversal Agent for Dabigatran
    Syed, Yahiya Y.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (04) : 297 - 304
  • [42] Concerns about idarucizumab for dabigatran reversal
    Stoellberger, Claudia
    Pommer, Peter
    Schneider, Birke
    Finsterer, Josef
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (04) : 473 - 474
  • [43] Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience
    Sanak, Daniel
    Jakubicek, Stanislava
    Cernik, David
    Herzig, Roman
    Kunas, Zdenek
    Mikulik, Robert
    Ostry, Svatopluk
    Reif, Michal
    Rohan, Vladimir
    Tomek, Ales
    Veverka, Tomas
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (09): : 2479 - 2483
  • [44] Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort
    Barber, P. Alan
    Wu, Teddy Y.
    Ranta, Annemarei
    NEUROLOGY, 2020, 94 (19) : E1968 - E1972
  • [45] Systemic thrombolysis and endovascular thrombectomy in severe acute ischemic stroke after dabigatran reversal with idarucizumab
    Binet, Quentin
    Hammer, Frank D.
    Rocrelle, Olivia
    Peeters, Andre
    Scavee, Christophe
    Hermans, Cedric
    CLINICAL CASE REPORTS, 2018, 6 (04): : 698 - 701
  • [46] Reversal of Anticoagulation Effect of Dabigatran with Idarucizumab, for Thrombolysis in Acute Ischemic Stroke: Inimicus Inimico Amicus
    Maramattom, Boby V.
    Thomas, Joe
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2019, 22 (04) : 515 - +
  • [47] Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation
    Yogaratnam, Dinesh
    Ditch, Kristen
    Medeiros, Kristin
    Doyno, Cassandra
    Fong, Jeffrey J.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (10) : 847 - 854
  • [48] Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
    Pollack, Charles V., Jr.
    Reilly, Paul A.
    van Ryn, Joanne
    Eikelboom, John W.
    Glund, Stephan
    Bernstein, Richard A.
    Dubiel, Robert
    Huisman, Menno V.
    Hylek, Elaine M.
    Kam, Chak-Wah
    Kamphuisen, Pieter W.
    Kreuzer, Joerg
    Levy, Jerrold H.
    Royle, Gordon
    Sellke, Frank W.
    Stangier, Joachim
    Steiner, Thorsten
    Verhamme, Peter
    Wang, Bushi
    Young, Laura
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05): : 431 - 441
  • [49] Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment
    Eikelboom, John W.
    van Ryn, Joanne
    Reilly, Paul
    Hylek, Elaine M.
    Elsaesser, Amelie
    Glund, Stephan
    Pollack, Charles V.
    Weitz, Jeffrey I.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (14) : 1760 - 1768
  • [50] Dabigatran reversal with idarucizumab prior to lung transplantation
    Harano, Takashi
    Rivosecchi, Ryan M.
    Morrell, Matthew R.
    Sanchez, Pablo G.
    CLINICAL TRANSPLANTATION, 2021, 35 (01)
12345